|
|
EY-01Y4467
|
1,1-Cyclobutanedicarboxylatodiammineplatinum
|
41575-94-4
|
250MG、1G、5G
|
￥0.0
|
|
|
|
EY-01Y4392
|
Diacetoxyscirpenol, 99%, from Fusarium sp.
|
2270-40-8
|
5MG、10MG
|
￥0.0
|
|
|
|
EY-01Y4408
|
Sulbactam, 98%, an irreversible β-lactamase inhibitor
|
68373-14-8
|
1G、5G
|
￥0.0
|
|
|
|
EY-01Y4512
|
Carbenicillin-Na2-salt research grade
|
4800-94-6
|
5G
|
￥0.0
|
|
|
|
EY-01Y4381
|
Carboplatin, 98%, a DNA synthesis inhibitor which binds to DNA, inhibits replication and transcription and induces cell death
|
41575-94-4
|
100MG
|
￥0.0
|
|
|
|
EY-01Y4417
|
Terbinafine hydrochloride, 98%
|
78628-80-5
|
1G、5G
|
￥0.0
|
|
|
|
EY-01Y4590
|
Blasticidin S hydrochloride
|
3513-03-9
|
50mg、25mg、250mg
|
￥0.0
|
|
|
|
EY-01Y4437
|
Sorbic acid solution, 1000 μg/mL in water
|
110-44-1
|
5ML
|
￥0.0
|
|
|
|
EY-01Y4387
|
Cefsulodin sodium salt, 98%
|
52152-93-9
|
200MG、1G
|
￥0.0
|
|
|
|
EY-01Y4537
|
Cefodizime
|
69739-16-8
|
50mg、100mg、25mg、1g、10g、50g
|
￥0.0
|
|
|
|
EY-01Y4447
|
Tanespimycin, 97%, a potent HSP90 inhibitor with an IC50 of 5 nM, having a 100-fold higher binding affinity for tumour cell derived HSP90 than normal cell derived HSP90
|
75747-14-7
|
10MG、25MG
|
￥0.0
|
|
|
|
EY-01Y4519
|
Tetracycline-HCl research grade
|
64-75-5
|
100G
|
￥0.0
|
|
|
|
EY-01Y4383
|
Tetracycline hydrochloride, 98%
|
64-75-5
|
25G、100G
|
￥0.0
|
|
|
|
EY-01Y4620
|
Tetracycline hydrochloride, 96%
|
64-75-5
|
25g、100g
|
￥0.0
|
|
